The project, titled Liver Immunocompetent Volumetric Engineering (LIVE), aims to address the shortage of donor organs by ...

The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...

The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...

Silk sericin, a glycoprotein traditionally regarded as a by‐product of silk fibroin extraction, has emerged as a promising biomaterial owing to its unique biological and physicochemical properties.

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...

After certain kinds of injuries or wounds — think heart attacks, burns and tendon tears, among others — scar tissue can form ...

Bone implants often fail to fully integrate with surrounding tissue, limiting their effectiveness in regeneration. A natural but often overlooked cellular process could hold the key to better outcomes ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...